All diseases

Disease Atlas / Disease detail

Trichomonas vaginitis / urogenital infection

This is an educational overview summarizing the definition, symptoms, testing, and management principles of Trichomonas vaginalis infection within the scope of the evidence.

Trichomonas vaginitis urogenital infection · Trichomonas vaginalis caused disease of genitourinary system · Trichomonas vaginalis disease of genitourinary system · Trichomonas vaginitis · urogenital infection by Trichomonas vaginalis

MONDO:0005993Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 7114cd328a05

Disease category
A urogenital infection caused by Trichomonas vaginalis, including trichomonal vaginitis.
Key mechanism
The cause is the parasite Trichomonas vaginalis, which is primarily transmitted between humans through sexual contact.
Main causes · related factors
Parasitic infection in the urogenital tract can cause localized inflammation and symptoms related to discharge and urination.
Representative patterns
In women, yellowish-green or gray vaginal discharge, vaginal odor, discomfort during intercourse, dysuria, itching, or burning may occur.
Individual differences
Sexual contact status and pregnancy status can affect clinical significance, and there is a large difference between asymptomatic and symptomatic individuals even when infected.
Diagnosis
Many people are asymptomatic, and if symptoms occur, they typically begin within 5–28 days after infection.
Management
Diagnosis is not confirmed based on clinical symptoms alone but centers on laboratory tests to confirm infection.
Treatment/Research Status
Since asymptomatic infections are common, the absence of symptoms alone cannot rule out infection, and other diseases may present with similar symptoms.
Read Evidence
The core of management involves confirming infection through testing, administering antibiotic treatment, and considering the evaluation and treatment of sexual partners concurrently.
Key Precautions
The MedlinePlus overview presents antibiotics as the treatment for trichomoniasis.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

A urogenital infection caused by Trichomonas vaginalis, including trichomonal vaginitis.

In women, yellowish-green or gray vaginal discharge, vaginal odor, discomfort during intercourse, dysuria, itching, or burning may occur.

How the disease works

The cause is the parasite Trichomonas vaginalis, which is primarily transmitted between humans through sexual contact.

Parasitic infection in the urogenital tract can cause localized inflammation and symptoms related to discharge and urination.

Variations in presentation among individuals

Sexual contact status and pregnancy status can affect clinical significance, and there is a large difference between asymptomatic and symptomatic individuals even when infected.

The broad framework of diagnosis and management

Many people are asymptomatic, and if symptoms occur, they typically begin within 5–28 days after infection.

Diagnosis is not confirmed based on clinical symptoms alone but centers on laboratory tests to confirm infection.

Current status of treatment

Since asymptomatic infections are common, the absence of symptoms alone cannot rule out infection, and other diseases may present with similar symptoms.

The core of management involves confirming infection through testing, administering antibiotic treatment, and considering the evaluation and treatment of sexual partners concurrently.

The MedlinePlus overview presents antibiotics as the treatment for trichomoniasis.

How to read clinical trials

ClinicalTrials.gov contains records of related intervention studies, but efficacy, safety, or whether they constitute standard treatment cannot be determined solely by registration status or the fact of completion.

Points to verify during clinical consultations

In clinical practice, it is possible to confirm symptoms and onset time, recent sexual contact and whether partners have been tested/treated, possibility of pregnancy, drug allergies, and possibility of re-exposure.

Medical Guidance

This material is for educational purposes and is not intended as a guide for individual diagnosis or treatment. If you have symptoms or concerns about exposure, please consult a healthcare professional.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.